key: cord-0947031-abrlyr8a authors: Pietre, E.; Amorim, G. P.; Bittencourt, M. F.; Ribeiro-Alves, M.; Acquarone, M. title: Prevalent comorbidities among young and underprivileged: Death portrait of COVID-19 among 235 555 hospitalized patients in Brazil date: 2021-01-25 journal: nan DOI: 10.1101/2021.01.22.21250346 sha: 1065d912bc8df29e36b68660c27e92fc304dbeaf doc_id: 947031 cord_uid: abrlyr8a Background COVID 19 has been alarmingly spreading worldwide, with Brazil ranking third in total number of cases and second in deaths. Being a continental country, which comprises many ethnic groups and an engrained social inequality, the pandemic evidenced this heterogeneous discrepancy. We aimed to estimate the impact of associated risk factors, isolated or combined, on COVID 19 severeness, detecting specific epidemiological profiles for multiple age ranges in hospitalized Brazilians. Methods In this large retrospective cohort study, we used open-access data from the Ministry of Health of Brazil with COVID 19 confirmed hospitalized patients annotated in SRAG system between February and August 2020, a total of 235555 entries. The association of COVID 19 death with socio-demographic and clinical characteristics was analysed and presented as odds ratios adjusted by confounding co-variables. We also presented marginal mean aOR values for high-order interactions either by or not another fixed level or condition. We kept all other variables in the multivariate logistic models in their mean values or equal proportions. Findings Younger individuals with one or more comorbidities had an adjusted odds ratio up to four-fold compared to those without it, in the same age interval. Younger diabetic patients either self-declared as brown ethnicity (aOR 5,58, 95% CI 4,97-6,25; p < 0,0001) or with some other associated comorbidities, mainly chronic hematologic disease (21,09, 13,64-32,6; p < 0,0001) and obesity (aOR 21,7, 95% CI not calculated; p < 0,0001), resulted in outstanding death risk. Age over 60, particularly over 90 (28,91, 24,5-34,11; p < 0,001), usage of invasive ventilatory support (16,23, 14,05-18,75; p < 0,001), admission to intensive care units (3,14, 2,82-3,48; p < 0,001), multiple respiratory symptoms (3,24, 2,79-3,75; p < 0,0001), black ethnicity (1,78, 1,52-2,07; p < 0,05), and diagnosis previous to hospitalization (1,32, 1,19-1,47; p < 0,05) were associated with higher death odds. As protective factors, with roughly one third less death risk, we found hospitalization duration of (4, 7] days and illness onset to hospitalization over 6 days. Interpretation We found evidence for increased COVID 19 risk in two distinct groups: younger patients with prevalent comorbidities, especially in brown ethnicity, and patients with black ethnicity. We speculate that the pro-inflammatory synergism of COVID 19 and comorbidities, promoting an overproduction of cytokines, is partially the cause of higher mortality in this young group. Brazilian black and brown are underprivileged populations, with structural social inequality, limited healthcare access and, thus, remarkable disease vulnerability. Our study supplies essential data to patient stratification upon admission, optimizing hospital management, and to guide public policy determinations, including group prioritization for COVID 19 vaccination in Brazil. nominal/categorical variables, we used bar plots, calculated absolute and relative frequencies, and tested independence with Fisher's exact tests. In determining factors associated with death risk and protection, we used fixed-effect generalized linear parametric models with a logistic link function (Binomial family). The measure of association was presented as a function of odds ratios either adjusted by co-variables of confounding (aOR) or not (OR). P-values were corrected by the number of comparisons with the reference level by the Holm-Sidak method. We kept all other variables in the multivariate logistic models in their mean values or equal proportions to estimate marginal mean aOR values and its 95% confidence intervals for high-order interactions either by or not another fixed level or condition. Again, p-values were corrected by the number of comparisons with the reference level by the Holm-Sidak method. All statistical analyses were performed in the software R v.3.6.3 and the library 'emmeans' and its dependencies. There was no funding source for this study. All authors had access to all used data. All authors have responsibility for the decision to submit the paper for publication. 2). Less frequent comorbidities were obesity, chronic renal disease, chronic neurological disease, chronic pneumopathy, immunodeficiency or immunosuppression, asthma, chronic hepatic disease, chronic hematologic disease, postpartum period, and down syndrome, respectively (Table 2) . Critical factors which increasingly impact outcomes, found as statistically significant by logistic analysis, were: respiratory distress, oxygen saturation < 95%, patients diagnosed with COVID-19 prior to hospitalization, dyspnea, use of non-invasive ventilatory support, black ethnicity, pre-existing chronic neurological disease, pre-existing immunodeficiency or immunosuppression, need of intensive care unit, age (60, 90], usage of invasive ventilatory support, and age greater than 90 (Table 3; Figure 1 ). As protective factors, illness onset prior to hospitalization greater than 6 but less than or equal 9 days, greater than 9 days, and patients with a hospitalization duration greater than 4 but less than or equal to 7 days (Table 3 ; Figure 1 ). The combination of oxygen saturation < 95%, dyspnea, and respiratory distress was shown to be the worst association of respiratory symptoms with death, followed by oxygen saturation < 95% with respiratory distress, oxygen saturation < 95% with dyspnea, and dyspnea with respiratory distress (Figure 2 ; appendix p 1). Regarding the impact of having one risk factor alone, patients aged (0, 20] had the worst outcome, followed by those (20, 40] , and those (40, 60] ( Figure 3 ; appendix p 1). To what concerns the impact of any two or more risk factors, patients aged (20, 40] had the worst outcome, followed by those (40, 60], and minor impact in (60, 80] ( Figure 3 ; appendix p 2). Finally, we analyzed the impact of diabetes mellitus (DM) combined with other risk factors on death, focusing on different age intervals. In patients up to 20 years old, DM, either with chronic hematologic diseases or obesity, leads to approximately a twenty-one-fold increase in death risk, followed by roughly a six-fold by brown ethnicity (white as reference) (Figure 4 ; appendix p 3). At age (20, 40], DM, either with chronic cardiovascular diseases or chronic high blood pressure, showed a four-fold increase in death risk ( Figure 4 ; appendix p 3). Yet, among the younger population, DM, when associated either with chronic neurological diseases, chronic pneumopathy diseases, chronic renal diseases, or unlisted risk factors, shows a recurring pattern of worse outcome ( Figure 4) . This large-scale retrospective cohort study identified and estimated the impact of several risk factors for death in COVID-19 Brazilian hospitalized patients, as well as their severe increase in association with diabetes. Individually, advanced age, invasive ventilatory support, admission to intensive care units, and multiple respiratory symptoms were associated with higher death odds. Usage of non-invasive ventilatory support, immunodeficiency or immunosuppression, black ethnicity, and COVID-19 diagnosis previous to hospitalization were also aggravating factors for death, with less impact. Younger diabetic patients either selfdeclared as brown ethnicity or with some comorbidities, mainly chronic hematologic disease and obesity, presented an outstanding death risk. As protective factors, we found hospitalization duration of (4, 7] and illness onset to hospitalization interval greater than 6 days. Fever and cough have been reported as the most prevalent COVID-19 symptoms worldwide, with substantial heterogeneity between countries. 7, 18, 19 Our study of hospitalized patients All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted January 25, 2021. ; https://doi.org/10.1101/2021.01.22.21250346 doi: medRxiv preprint confirmed this fact, with fever reported in 67·4% of cases and cough in 72·8%. Compared with other countries, the prevalence found in our data was among the highest for both symptoms, with 32% in Korea and 83% in Singapore for fever and 18% in Korea and 76% in the Netherlands for cough. 18 Although high prevalence, no statistically significant impact on death was found here in Brazil. Many other countries, such as Italy, 20 Spain, 21 and Egypt, 22 found a correlation of dyspnea or low oxygen saturation with higher hospital deaths. Our data corroborate this, showing that a combination of both symptoms more than doubles hospital death risk. Additionally, respiratory distress and the association of multiple respiratory symptoms are important risk factors, with Brazilian patients manifesting all three respiratory symptoms having an approximately three-fold increase in death risk. Regarding the usage of intensive care units, invasive ventilatory support and non-invasive ventilatory support, our data shows respectively 30·2%, 18·5% and 37·5%, higher than the respectively formerly reported 17%, 9% and 19% among worldwide hospitalized patients. 18 Unfortunately, almost half of COVID-19 Brazilian hospitalized patients are only diagnosed during admission. Despite one of the countries with most cases, Brazil is in 125 th place in the number of SARS-CoV-2 real-time polymerase chain reaction exams per million inhabitants. 23 We suggest that the high usage of intensive care units and ventilatory support in Brazil, compared to elsewhere, may be in part due to late COVID-19 diagnosis. This fact reflects significant disparities in health care accessibility and socioeconomic inequalities throughout the country. 24 Hospitalization duration of (4, 7] and illness onset to hospitalization interval greater than 6 days as protective factors are probably related to viral shedding. Better understanding of this dynamic is a must for optimizing pandemic hospital management in Brazil and saving lives, especially for risk groups composed of subpopulations. Aging leads to a natural decline in the immune system and a chronic inflammatory state, 25 and has been reported as a biological vulnerability for COVID-19 mortality. 21,26,27 We also found age greater than 60 as a prominent risk factor, particularly over 90 years. A nationwide large cohort study in the United Kingdom showed that while age is per se an independent risk factor, the mortality on elderly patients is partially explained by the higher prevalence of comorbidities, such as poorer lung function, hypertension, muscle weakness, and multiple long-term conditions. 27 Conversely, our data revealed that the impact of having one or a combination of two or more risk factors on mortality are progressively higher in ages (60, 80], (40, 60], (20, 40] , and (0, 20] compared with people of the same age interval without comorbidities. This discrepancy could be due to the British study using, as a reference group, people less than 65 years old with or without comorbidities. The synergism of COVID-19, pro-inflammatory comorbidities and a young immune profile, leading to overproduction of cytokines, must be further investigated as it partially explains the higher mortality in this intersection group. Beyond advanced age, some features, as ethnicity and gender, have been also identified as biological concern for COVID-19 mortality. 28, 29 Although over half of the hospitalized patients were men, gender independently was not statistically associated with higher hospital death risk in Brazil, despite other reports which associate male sex with worse in-hospital outcomes. 30 Still, biological factors underlying higher mortality in ethnic groups are limited and need to be further addressed. We observed young brown individuals with diabetes and black ethnicity as population subgroups at higher risk for severe COVID-19. A longitudinal analysis of 2012-16 economic recession in Brazil showed an increase in mortality in the same groups, due to All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted January 25, 2021. ; https://doi.org/10.1101/2021.01.22.21250346 doi: medRxiv preprint socioeconomic factors, labour market participation, and underlying morbidities. 31 As in past economic crises, actual pandemics highlights Brazilian social and health care access inequalities. Historically, compared with white, black and brown Brazilians have lower schooling levels, a higher index of informal jobs, lower incomes, and restricted access to the health care system, 32 particularly for men. 33 Other study showed that COVID-19 death rate is higher in these Brazilians subpopulations and might be partly due to non-ICU admission, especially for brown. 34 We also found brown ethnicity as a independent risk factor prior to using ventilatory support and ICU usage as confounding variables, what supports the former study hypothesis. 34 Diabetes Mellitus is often associated with other comorbidities and has been consistently correlated with an increase in severity and mortality of COVID-19 patients. 14,35 Diabetes, high blood pressure, chronic renal diseases, Alzheimer disease, pneumopathy, and obesity are conditions that lead to an upregulation expression of ACE2, resulting in increased viral uptake, turning them into susceptible sites. 36,37 ACE2 (Angiotensin-converting enzyme 2) is one of the surface receptors used by SARS-CoV-2 to enter host cells, and it is constitutively expressed in a wide variety of epithelial, non-epithelial cells, and organs as lungs, heart, kidneys, and adipocyte tissue. 36,38 Those tissues normally express higher amounts of ACE2 receptor, added to the fact that some conditions potentially increased ACE2 expression. This combination partially explains higher death risk in COVID-19 patients with comorbidities. The infection itself can cause deleterious effects on immunity, and a synergic event between diseases causes hyperactivity of the immune system, leading to a chronic proinflammatory state, what contributes to the cytokine storm seen in some severe COVID-19 patients. 14,36 Our study has some key limitations, mainly regarding data quality, annotation accuracy, suspected under-reported data, and lack of government open-access information of nonhospitalized patients in Brazil. This is a relevant bias as studies based only on hospitalized patients are focused on more severe cases and fatalities. Furthermore, we cannot guarantee that missing information is not subject to bias. Although extensive, some fundamental information that greatly affects the prognosis of the disease is missing in the SRAG form, mainly regarding smoking, alcohol intake, oncological disorders, and chronic high blood pressure. 39-42 As for our study's relevance, drawing attention to diabetes, lack of reliable data on Body Mass Index (BMI) prevented us from differentiating the impact of obesity and severe obesity in mortality. This is mainly important because obesity is a chronic inflammatory condition associated with cardiometabolic and immune dysfunction, increased risk of diabetes and hematological disease, leading patients to be more susceptible to develop severe forms of COVID-19. 36 The underreporting in the BMI may be aggravated due to professionals being not properly instructed on how to use and fill out the form items. Thus, we suggest remodeling the form, together with better orientation on how to deal with information gathering. Nonetheless, despite all Brazilian health system challenges, the average notification delay was 0 days (IQR=2), demonstrating high efficiency in national information flow. To the best of our knowledge, this is the largest retrospective cohort study of hospitalized Brazilians COVID-19 patients up to date. Older age, multiple respiratory symptoms, younger patients with some risk factor, and younger diabetics with multiple comorbidities are risk groups that play an important role in the death by COVID-19 scenario. Globally, measures have been focused on health workers and older patients as risk groups and priority for vaccination. All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in Our findings have shone a spotlight upon a risk group that is so far neglected in Brazil, as younger patients with comorbidities and younger diabetic patients with further comorbidities. The understanding of how comorbidities increased risk mortality by COVID-19 is fundamental for implementing appropriate public health and therapeutic strategies. We expect this meaningful nationwide analysis to be highly considered to help establish patient risk stratification upon admission, optimizing hospital management, and guide public policy determinations, including group prioritization for COVID-19 vaccination and vulnerable populations health care accessibility in Brazil. EP conceived the research question. EP, GPA, MRA and MA designed the study and analyses plan. EP obtained and performed initial data cleanup. MRA carried out the analyses. EP and GPA drafted the initial version of the manuscript. All authors drafted and edited the final version of the manuscript. MFFB performed spelling and grammar reviewing. All authors had access to all used data. All authors critically reviewed and approved the final version of the manuscript. We declare no competing interests. SRAG data is publicly available on the Ministry of Health of Brazil website. The analysis source code will be available upon request to the authors. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in Death and cure proportions represented by n (%). Schooling level expressed as the number of years of study. Adj=Adjusted. *P-values were corrected by the number of comparisons with the reference level by the Holm-Sidak method. †Odds Ratios were adjusted by all significant variables in bivariate models (OR) and added as confounding variables in the multivariate logistic models (aOR) whenever applicable. ‡Up to 45 days after giving birth. **Diagnosed and notified as COVID-19 before hospitalization. ***Zero included in the unknown. All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in For each feature, aOR was estimated against its reference (Table 3 ), its mean represented by the dot and the 95% CI given by the respective black line. Vertical dotted line at aOR = 1. All significant variables in bivariate models were added as confounding variables in the multivariate logistic models. Illness onset to hosptalization 9 Illness onset to hosptalization ( , 9 Hospitalization time (4, perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted January 25, 2021. ; https://doi.org/10.1101/2021.01.22.21250346 doi: medRxiv preprint For each respiratory symptoms combination, the aOR was estimated against subjects without all three respiratory symptoms (appendix p 1), its mean represented by the dot and the 95% CI given by the respective black line. Vertical dotted line at aOR = 1. The confounding variables, i.e., ethnicity, ventilatory support, and intensive care unit, were kept in equal proportions in the multivariate logistic models. R. distress=Respiratory distress. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in For each number of risk factors and age combination, the aOR was estimated against its reference (appendix p 2), its mean represented by the dot and the 95% CI given by the respective black line. Vertical dotted line at aOR = 1. The confounding variables, i.e., ethnicity, ventilatory support, and intensive care unit, were kept in equal proportions in the multivariate logistic models. RF= Risk Factor. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in For each number of risk factors and age combination, the aOR was estimated against its reference (appendix p 3), its mean represented by the dot and the 95% CI given by the respective black line. Vertical dotted line at aOR = 1. The confounding variables, i.e., ethnicity, ventilatory support, and intensive care unit, were kept in equal proportions in the multivariate logistic models. * 95% CI not calculated. DM=Diabetes Mellitus. CHD=Chronic Hematologic Disease. OB=Obesity. BE=Brown Ethnicity. CHBP=Chronic High Blood Pressure. CVD=Chronic Vascular Disease. CND=Chronic Neurologic Disease. CPD=Chronic Pneumopathy Disease. CRD=Chronic Renal Disease. UR ='Unlisted Risk actors'. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted January 25, 2021. ; https://doi.org/10.1101/2021.01.22.21250346 doi: medRxiv preprint Coronaviruses and SARS-CoV-2: A Brief Overview COVID-19 in Latin America: The implications of the first confirmed case in Brazil World Health Organization. WHO Director-General's statement on IHR Emergency Committee on Novel Coronavirus (2019-nCoV) World Health Organization. WHO Director-General's opening remarks at the media briefing on COVID-19 -11 World Health Organization. WHO Coronavirus Disease (COVID-19) Dashboard The World Bank. Population, total | Data Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China Enteric involvement in hospitalised patients with COVID-19 outside Wuhan